Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
June-2019 Volume 43 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2019 Volume 43 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Protective effects of tyndallized Lactobacillus acidophilus IDCC 3302 against UVB‑induced photodamage to epidermal keratinocytes cells

  • Authors:
    • A‑Rang Im
    • Byeonghun Lee
    • Dae‑Jung Kang
    • Sungwook Chae
  • View Affiliations / Copyright

    Affiliations: Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea, Bioprocess Engineering Team, Research Laboratories, ILDONG Pharmaceutical Co., Ltd., Hwaseong, Gyeonggi 18449, Republic of Korea
  • Pages: 2499-2506
    |
    Published online on: April 10, 2019
       https://doi.org/10.3892/ijmm.2019.4161
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Photoaging is a consequence of chronic exposure to ultraviolet (UV) radiation and results in skin damage. In this study, whether tyndallizate of the probiotic bacterium Lactobacillus acidophilus IDCC 3302 (ACT 3302) can protect against UVB‑induced photodamage to the skin was investigated. For this, HaCaT keratinocytes were used as a model for skin photoaging. HaCaT cells were treated with ACT 3302 prior to UVB exposure and skin hydration factors and matrix metalloproteinase (MMP)‑1, MMP‑2, and MMP‑9 levels in the culture supernatant were evaluated by ELISA. The protective effects of ACT 3302 against UVB‑induced oxidative stress in HaCaT cells was also assessed by measuring superoxide dismutase and catalase activity and detecting the expression of pro‑inflammatory cytokine‑encoding genes and mitogen‑activated protein kinase (MAPK) signaling components by reverse transcription‑quantitative polymerase chain reaction and western blotting, respectively. UVB exposure increased MMP expression and MAPK activation; these changes were attenuated by pretreatment with ACT 3302. Treatment with ACT 3302 prior to UVB exposure also attenuated inflammation. These results demonstrate that tyndallized ACT 3302 can mitigate photodamage to the skin induced by UVB radiation through the suppression of MMPs and could therefore be used clinically to prevent wrinkle formation.

Introduction

Extrinsic aging is caused by environmental oxidative factors that can be primarily attributed to exposure to ultraviolet (UV) radiation (1). A variety of environmental stresses including UV light can damage sun-exposed areas of the skin including the face and neck, and accelerate wrinkle formation (2), which is a cumulative process that depends on the frequency, duration, and intensity of UV exposure and the degree of natural protection offered by skin pigmentation (3). In addition to wrinkling, skin aging manifests as solar elastosis and pigment irregularities (4).

UVB radiation alters the thickness of the stratum corneum of the epidermis and consequently, the permeability barrier, leading to increased transepidermal water loss (TEWL) (5). Several factors control skin moisturization and elasticity, including the content of hyaluronan (HA), an extracellular matrix (ECM) component and transforming growth factor (TGF)-β, in addition to regulators of the expression of ECM macromolecules (6). Collagen has been used as a functional ingredient in skin products based on its efficacy in moisturizing and enhancing elasticity. Furthermore, involucrin and filaggrin are major proteins that serve an important role in the formation of the epidermal skin barrier (7). Changes to the dermal ECM during photoaging involve the abnormal production of matrix proteins by dermal fibroblasts and increased the activity of matrix-degrading enzymes such as matrix metalloproteinases (MMPs) by resident skin cells and infiltrating inflammatory cells (8). Also involved is decreased procollagen synthesis, resulting in the loss of skin elasticity, which leads to wrinkle formation (9).

Reactive oxygen species (ROS) produced in the skin upon UV irradiation cause oxidative damage to the skin (10) by mediating impaired cellular and ECM functions (11,12). UVB radiation induces cellular damage, leading to activation of ROS-sensitive signaling pathways including the mitogen-activated protein kinase (MAPK) pathway (13), which mediates inflammatory cytokine production (14). Accordingly, antioxidants can protect the skin from UVB radiation-induced skin damage (15).

Probiotics have been widely used to regulate intestinal health and treat medical conditions including allergic diseases and atopic dermatitis, as well as to prevent dental caries and respiratory infections (16). The most common microorganisms used as probiotic bacteria, which include Lactobacillus, Bifidobacterium and Streptococcus, mainly affect health and improve gastrointestinal tract homeostasis in the host by modulating the balance in the gut environment (17). Tyndallized probiotics, which are processed in their culture media, contain bacterial walls; moreover, the products released during their cell death have been demonstrated to positively affect human health and maintain their immunological effect on the gut barrier (18). It has been reported that probiotic bacteria may be highly effective in protecting the skin from photoaging, as oral supplementation prior to UVB exposure was demonstrated to prevent TEWL, increase epidermal thickness, and alleviate damage to tight junction structures and the basement membrane in a mouse model (19,20). The probiotic gram-positive bacterium Lactobacillus acidophilus inhabits the intestines and serves an important role in the maintenance of gut health; however, it is not known whether it can protect against photoaging induced by UV radiation.

This was addressed in the present study using HaCaT keratinocytes treated with Lactobacillus acidophilus IDCC 3302 tyndallizate (ACT 3302) prior to UVB exposure. Lactobacillus acidophilus IDCC 3302 (GenBank accession number KP325412.1) was originally isolated from the feces of a Korean breast-fed infant after obtaining oral consent from the parents. The materials used in the present experiments were not directly separated from human feces, but were commercially available materials produced by Il-dong Pharmaceutical. The results of the present study indicated that ACT 3302 treatment can prevent photodamage to the skin by inhibiting MMP activation through the modulation of MAPK signaling.

Materials and methods

Materials

Dulbecco’s modified Eagle’s medium (DMEM) and fetal bovine serum (FBS) were purchased from Gibco (Thermo Fisher Scientific, Inc., Waltham, MA, USA). The CellTiter AQueous One Solution Cell Proliferation Assay kit and 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4- sulfophenyl)-2H- tetrazolium (MTS) were purchased from Promega Corporation (Madison, WI, USA). Human HA and MMP-1, MMP-2 and MMP-9 ELISA kits were obtained from R&D Systems, Inc., (Minneapolis, MN, USA). Antibodies targeting MAPK kinase (MEK), phosphorylated (p)MEK, extracellular signal-regulated kinase 1 and 2 (ERK1/2), pERK1/2, p38, pp38, c-Jun N-terminal kinase (JNK), pJNK, procollagen, and β-actin were purchased from Cell Signaling Technology, Inc., (Danvers, MA, USA). Secondary antibodies were purchased from Santa Cruz Biotechnology, Inc., (Santa Cruz, CA, USA).

Tyndallization process

Bacterial cells were anaerobically cultured in yeast extract-based medium at 37°C overnight and then centrifuged at 12,500 × g for 1 h at room temperature using a continuous filter (Alfa Laval, Lund, Sweden). Thereafter, the pellets and the supernatant were concentrated 5 times using a vacuum concentrator (Dong Yang Machine Industry, Seoul, Korea) under reduced pressure at 80°C and then mixed with dry-sterilized cornstarch powder. The cornstarch was not effective on wrinkle reduction. The mix was then frozen at −45°C and lyophilized to obtain ACT 3302 powder.

Total bacterial cell numbers

ACT 3302 cell samples were diluted 103-fold in PBS and cell particles in 25 small squares were counted using a Neubauer counting chamber (Paul Marienfeld GmbH & Co., KG, Lauda-Königshofen, Germany), with 2.5×10−4-mm3 squares, at a magnification of ×400. The number of cells was calculated as follows: Bacterial cell number per ml=average number of counted cells per square ×4,000 squares per mm3×103 mm3 per mlx103 (dilution).

Cell culture and UVB irradiation

HaCaT cells (cell lines service, 300493)-an immortalized, non-tumorigenic human keratinocyte cell line were maintained in DMEM supplemented with 10% FBS and 1% antibiotics (Penicillin-Streptomycin; Gibco; Thermo Fisher Scientific, Inc.) at 37°C in a humidified incubator with 5% CO2. Cells were seeded (1×104), allowed to adhere for 24 h and treated with various concentrations (1×105, 1×106, 1×107 and 1×108) of ACT 3302 prior to UVB irradiation at a dose of 20 mJ/cm2. Normal cells received no ACT 3302 and were not exposed to UVB radiation. Vehicle cells received no ACT 3302, but were exposed to UVB radiation.

Cell viability assay

HaCaT cells (1×104) were seeded in 96-well culture plates and exposed to 20 mJ/cm2 UVB in the presence or absence of ACT 3302 for 24 h. The cell culture medium was replaced with PBS prior to UVB treatment and cell viability was assessed immediately following this by incubating cells with MTS (Promega Corporation) containing serum free medium for 1 h. MTS containing serum free medium was measured according to the manufacturer’s protocol; specifically, sample absorbance was measured at 490 nm using a microplate fluorimeter (Molecular Devices, LLC, Sunnyvale, CA, USA).

Determination of HA, MMP-1, MMP-2 and MMP-9 secretion by ELISA

HA (cat. no. DHYAL0), MMP-1 (cat. no. DMP100), MMP-2 (cat. no. MMP200) and MMP-9 (cat. no. DMP900) levels in HaCaT cell culture supernatant (5×104), following UVB irradiation, were determined using ELISA kits according to the manufacturer’s protocol. Briefly, the cells were seeded in 96-well plates and treated with ACT 3302. After cells were treated with ACT 3302 for 24 h, the medium was removed and then replaced with new medium for ELISA analysis. After UVB irradiation, the culture supernatant was collected and centrifuged at 18,928 × g for 5 min at 4°C and HA, MMP-1, MMP-2, and MMP-9 levels were quantified colorimetrically.

Antioxidant enzyme activities

Total protein was extracted from HaCaT cells, which were homogenized in cold lysis buffer, superoxide dismutase (SOD) and catalase (CAT) activities were measured using colorimetric assay kits (Cayman Chemical, Ann Arbor, MI, USA) according to the manufacturer’s protocol. SOD and CAT activities were determined by measuring the absorbance at 450 and 540 nm, respectively, using a plate reader (Molecular Devices, LLC).

RNA extraction and Taqman multiplex PCR assay

Total RNA was extracted from UVB-irradiated HaCaT cells, using TRIzol reagent according to the manufacturer’s protocol (Invitrogen; Thermo Fisher Scientific, Inc.). RT-qPCR was performed using TaqMan assays (Applied Biosystems; Thermo Fisher Scientific, Inc.) specific for involucrin, filaggrin, TGF-β, interleukin (IL)-1β, IL-8, and tumor necrosis factor (TNF)-α (involucrin; Hs00846307_s1, filaggrin; Hs00856927_g1, TGF-β; Hs00998133_m1, IL-1β; Hs00174097_m1, IL-8; Hs00174103_ m1 and TNF-α; Hs01113624_g1) with a QuantStudio 6 Flex Real-Time PCR system (Applied Biosystems; Thermo Fisher Scientific, Inc.). The thermocycling conditions were as follows: 95°C for 10 min, 40 cycles of denaturation at 95°C for 15 sec, followed by annealing and extension at 60°C for 1 min. Each sample was assayed in triplicate and relative mRNA expression levels were calculated using the ΔΔCq method (21) and normalized to that of β-actin in each sample.

Western blotting

To extract total protein, HaCaT cells were homogenized and lysed in RIPA assay buffer containing a protease inhibitor (ATTO Corporation, Tokyo, Japan). Protein (15 µg) was separated by SDS-PAGE on a 10% polyacrylamide gel and then transferred to a polyvinylidene difluoride membrane, which was then incubated overnight at 4°C with the following primary antibodies (all, 1:1,000): Procollagen (cat. no. 84336), pERK (cat. no. 9101), ERK (cat. no. 9102), pMEK (cat. no. 9154), MEK (cat. no. 9126), pp38 (cat. no. 9215), p38 (cat. no. 9212), pJNK (cat. no. 9251), JNK (cat. no. 9252), and β-actin (cat. no. 4970). The membrane was washed three times for 10 min each with PBS containing 0.1% tween 20, which was followed by incubation for 2 h at room temperature with appropriate horseradish peroxidase conjugated anti-rabbit secondary antibodies (1:10,000; cat. no. 7074; Cell signaling Technology, Inc.). Protein bands were visualized using an enhanced chemiluminescence kit (Thermo Fisher Scientific, Inc.) and analyzed using ImageQuant LAS 4000 (GE Healthcare).

Statistics

Measurements were performed in triplicate and all data are presented as the mean ± standard error of the mean. The significance of differences between groups was evaluated by performing an analysis of variance with Tukey’s multiple comparisons test with GraphPad Prism version 7.03 software (GraphPad Software, Inc.). P<0.05 was considered to indicate a statistically significant difference.

Results

ACT 3302 increases cell viability and protects against UVB-induced cell damage in keratinocytes

The effect of ACT 3302 on HaCaT cell proliferation following exposure to UVB was investigated first. Cell viability was reduced to 49.4% of normal levels by UVB irradiation. In cells preincubated with 1×108 ACT 3302 cells, cell viability was 81.4% of normal levels following irradiation in dose-dependent manner and this difference was significant (P<0.001; Fig. 1).

Figure 1

Viability of human keratinocytes following UVB exposure. HaCaT cells were pretreated with various concentrations of Lactobacillus acidophilus IDCC 3302 for 24 h and then irradiated. The normal group is the vehicle group with no UVB treatment. Data are presented as percentages relative to the normal group. ###P<0.001 vs. the normal group; *P<0.05 and ***P<0.001 vs. the UVB vehicle group. UVB, ultraviolet B.

Effect of ACT 3302 on UVB-induced secretion of skin hydration factors

The effect of ACT 3302 on UVB-induced secretion of skin hydration factors, namely epidermal ECM components was also determined. UVB irradiation decreased HA levels, as determined by ELISA (Fig. 2A), indicating that ECM breakdown induced by UVB radiation contributes to skin aging. HA levels were increased significantly (P<0.001) in a dose dependent manner. In addition, it was demonstrated that the expression of involucrin, filaggrin, and TGF-β was decreased by UVB. The mRNA expression of involucrin, filaggrin, and TGF-β in UVB-induced cells treated with ACT 3302 increased in a dose-dependent manner, as compared to that in UVB-exposed cells (Fig. 2B-D).

Figure 2

Effects of Lactobacillus acidophilus IDCC 3302 on skin hydration factors. (A) HA levels in UVB-induced HaCaT cells. (B) Involucrin, (C) filaggrin and (D) TGF-β mRNA expression levels were evaluated by reverse transcription-quantitative polymerase chain reaction. Normal means the vehicle group with no UVB treatment. #P<0.05, ##P<0.01 and ###P<0.001 vs. normal group; *P<0.05, **P<0.01 and ***P<0.001 vs. UVB vehicle group. TGF, transforming growth factor; UVB, ultraviolet B; HA, hyaluronan.

ACT 3302 protects HaCaT cells from oxidative stress and suppresses inflammation in response to UVB radiation

To determine whether ACT 3302 can promote radical scavenging, the activities of antioxidant enzymes in HaCaT cells exposed to UVB were examined. SOD activity in vehicle group was reduced compared with the untreated normal group (0.53 vs. 4.96 U/ml; Fig. 3A). Also, CAT was significantly reduced in UVB-induced cells compared with normal cells (P<0.01; Fig. 3B). However, SOD and CAT activity were enhanced by ACT 3302 but SOD was saturated at 1×108 of ACT 3302. Therefore, ACT 3302 stimulates the activity of antioxidant enzymes that scavenge free radicals and thereby prevents UVB-induced oxidative stress damage. It was also demonstrated that mRNA levels of the pro-inflammatory cytokines IL-1β, IL-8, and TNF-α were significantly upregulated in keratinocyte cells upon UVB exposure (P<0.05), which was reversed by ACT 3302 treatment (Fig. 4). This suggests that ACT 3302 exerts a protective effect by reducing the inflammatory response to UVB irradiation.

Figure 3

Effects of ACT 3302 on antioxidant enzyme activity in human keratinocytes. (A) SOD and (B) CAT activities were examined in HaCaT cells exposed to UVB following pretreatment with ACT 3302. Normal means the vehicle group with no UVB treatment. ###P<0.001 vs. normal group; **P<0.01 and ***P<0.001 vs. UVB vehicle group. SOD, superoxide dismutase; CAT, catalase; UVB, ultraviolet B; ACT 3302, Lactobacillus acidophilus IDCC 3302.

Figure 4

Effects of Lactobacillus acidophilus IDCC 3302 on pro-inflammatory cytokine levels in UVB-irradiated HaCaT cells. (A) IL-1β, (B) IL-8 and (C) TNF-α mRNA expression levels were evaluated by reverse transcription-quantitative polymerase chain reaction. Normal means vehicle group with no UVB treatment. #P<0.05 and ###P<0.001 vs. normal group; *P<0.05, **P<0.01 and ***P<0.001 vs. UVB vehicle group. IL, interleukin; TNF, tumor necrosis factor; UVB, ultraviolet B.

ACT 3302 prevents UVB-induced damage to keratinocytes by inhibiting MAPK signaling

To clarify the mechanism through which ACT 3302 protects keratinocytes from UVB-induced damage, MMP levels in the culture supernatant were detected by ELISA following UVB irradiation. UVB irradiation significantly increased MMP-1, MMP-2, and MMP-9 levels in HaCaT cells (P<0.001), but this effect was significantly abolished by pre-treatment with ACT 3302 in a dose-dependent manner (P<0.001; Fig. 5A-C). Also, ACT 3302 treatment reversed this trend and increased procollagen phosphorylation (Fig. 5D).

Figure 5

Effects of ACT 3302 on MMP expression and pro-col levels in UVB-irradiated human keratinocytes. HaCaT cells were treated with ACT 3302 for 24 h before UVB irradiation. (A) MMP-1, (B) MMP-2 and (C) MMP-9 levels in the culture supernatant were detected by ELISA. (D) Pro-col protein levels were determined by western blotting. Normal means the veh group with no UVB treatment. ###P<0.001 vs. nor group; ***P<0.001 vs. UVB veh group. MMP, matrix metalloproteinase; UVB, ultraviolet B; ACT 3302, Lactobacillus acidophilus IDCC 3302; Nor, normal; Veh, vehicle; procol, procollagen.

Additionally, the increase in p38, JNK, and MAPK/ERK phosphorylation induced by UVB irradiation was significantly decreased by ACT 3302 (P<0.001). These data indicate that ACT 3302 protects HaCaT cells from UVB-induced damage by inhibiting the activity of ECM-degrading proteins, and this occurs through the modulation of MAPK signaling (Fig. 6).

Figure 6

Effects of ACT 3302 on ERK, MEK, p38 and JNK phosphorylation in the UVB-irradiated HaCaT cells. (A) ACT 3302 inhibited the phosphorylation of ERK, MEK, p38 and JNK as determined by western blotting. (B) Relative intensity of data from western blot analysis was analyzed. Normal means the vehicle group with no UVB treatment. ###P<0.001 vs. normal group; ***P<0.001 vs. UVB vehicle group. JNK, c-Jun N-terminal kinase; ERK, extracellular signal regulated kinase; MEK, dual specificity mitogen-activated protein kinase kinase 1; UVB, ultraviolet B; ACT 3303, Lactobacillus acidophilus IDCC 3302.

Discussion

The present study demonstrated the protective effect of L. acidophilus IDCC 3302 tyndallizate on HaCaT keratinocyte damage induced by UVB exposure. Tyndallizate was analyzed for its nutrients including carbohydrate, crude protein, crude fat, moisture, and ash (22). For small molecule analysis, lactic acid was detected as a major chemical component and it is reported that topical lactic acid has cosmetic benefit (22). In previous studies, beneficial effects of short-chain fatty acids and vitamins produced by probiotics have been reported (23,24). In this study, tyndallizate was hypothesized to be helpful in skin rejuvenation. The detailed mechanisms regarding anti-wrinkle activity require further study.

Skin aging is mainly caused by repeated sun exposure (25). Intrinsically aged skin is characterized by fine wrinkling and reduced elasticity, whereas extrinsically aged skin exhibits deep wrinkles, pigment irregularities, and a substantial loss of elasticity (26,27). Exposure to UV radiation leads to the deposition of abnormal elastin complexes and the denaturation of collagen fibers (28), as well as increased epidermal thickness and alterations in connective tissue organization (29,30). Involucrin is a differentiation marker normally expressed by irreversibly differentiated keratinocytes in the stratum corneum; in a previous study, downregulation of filaggrin was demonstrated to be involved in skin reconstruction in vitro following UVB exposure (31,32). In this study, the upregulation of HA, involucrin, filaggrin, and TGF-β, an epidermal ECM component that serves an essential role in supporting tissue architecture in the skin and epidermis and protects skin from dryness caused by UVB exposure was observed.

Collagen protects skin from photodamage (33). Type I collagen, which forms the bulk of skin connective tissue in the dermis, is gradually lost during the aging process (34). Exposure to UV radiation can cause collagen breakdown, fragmentation, and disorganization, as well as the inhibition of procollagen biosynthesis (35). In this study, western blot analysis revealed that the downregulation of procollagen expression, relative to that in the normal group, upon UVB irradiation was also reversed by ACT 3302.

Increased activity of MMPs due to chronic sun exposure promotes dermal ECM fragmentation, causing the aged appearance of skin (36). Multiple MMPs including MMP-1 and MMP-9 in the human skin dermis are upregulated during aging, but this is exacerbated by exposure to UV light from the sun (37). In particular, MMP-1 serves an important role in the degradation of dermal collagens in the ECM (38). Indeed, in this study it was observed that MMP-1, MMP-2, and MMP-9 levels were increased in HaCaT cells upon UVB irradiation, it was reversed by ACT 3302.

ROS are involved in a variety of physiological processes including intracellular signaling, cell proliferation, tumor suppression, immune defense against pathogens, and oxygen homeostasis (39). Following UVB irradiation, SOD and CAT activities were suppressed; however, ACT 3302 stimulated antioxidant enzyme activity and thereby prevented UVB-induced oxidative stress.

Exposing the skin to UV radiation can induce immune suppression and can lead to inflammation (40). In keratinocytes, UVB induces the synthesis of various pro-inflammatory cytokines including TNF-α, IL-1, IL-6, IL-8, and IL-10, leading to the activation of nuclear factor-κB signaling (41). In the present study, UVB irradiation increased IL-1β, IL-8, and TNF-α levels in HaCaT cells, it was abolished by ACT 3302.

UVB irradiation induces the production of ROS and activates cell surface receptors, leading to the activation of MAPK signaling, which involves JNK, ERK and p38 (42). MAPK transmits extracellular signals to the nucleus and is one of the most important signal transduction pathways activated by UVB radiation (43). The present study identified that ACT 3302 inhibited the UVB-induced activation of JNK, p38, MEK and ERK.

In conclusion, it was demonstrated that ACT 3302 reduces skin damage caused by UVB radiation by increasing the activity of antioxidant enzymes and skin hydration factors, as well as by suppressing MMP levels along with pro-inflammatory cytokine production through the inhibition of MAPK signaling pathway. The results of the present study provide evidence that probiotics are not only important for maintaining gut health but can have additional (cosmetic) benefits such as preventing skin aging.

Funding

The present study was supported by the Korea Institute of Oriental Medicine (grant no. K17300).

Availability of data and materials

All data generated or analyzed during the present study are available upon reasonable request.

Authors’ contributions

AI, BL, DK and SC conceived and designed the current study, and acquired the data. AI and BL performed the experiments and analyzed the data. SC revised and gave final approval of the current version to be published. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Acknowledgments

Not applicable.

References

1 

Jenkins G: Molecular mechanisms of skin ageing. Mech Ageing Dev. 123:801–810. 2002. View Article : Google Scholar : PubMed/NCBI

2 

Kammeyer A and Luiten RM: Oxidation events and skin aging. Ageing Res Rev. 21:16–29. 2015. View Article : Google Scholar : PubMed/NCBI

3 

D’Orazio J, Jarrett S, Amaro-Ortiz A and Scott T: UV radiation and the skin. Int J Mol Sci. 14:12222–12248. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Rittié L and Fisher GJ: UV-light-induced signal cascades and skin aging. Ageing Res Rev. 1:705–720. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Lim SH, Kim SM, Lee YW, Ahn KJ and Choe YB: Change of biophysical properties of the skin caused by ultraviolet radiation-induced photodamage in Koreans. Skin Res Technol. 14:93–102. 2008.PubMed/NCBI

6 

Dai G, Freudenberger T, Zipper P, Melchior A, Grether-Beck S, Rabausch B, de Groot J, Twarock S, Hanenberg H, Homey B, et al: Chronic ultraviolet B irradiation causes loss of hyaluronic acid from mouse dermis because of down-regulation of hyaluronic acid synthases. Am J Pathol. 171:1451–1461. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Steinert PM and Marekov LN: The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem. 270:17702–17711. 1995. View Article : Google Scholar : PubMed/NCBI

8 

Bosset S, Bonnet-Duquennoy M, Barré P, Charlon A, Kurfurst R, Bonté F, Schnébert S, Le Varlet B and Nicolas JF: Photoageing shows histological features of chronic skin inflammation without clinical and molecular abnormalities. Br J Dermatol. 149:826–835. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Fligiel SE, Varani J, Datta SC, Kang S, Fisher GJ and Voorhees JJ: Collagen degradation in aged/photodamaged skin in vivo and after exposure to matrix metalloproteinase-1 in vitro. J Invest Dermatol. 120:842–848. 2003. View Article : Google Scholar : PubMed/NCBI

10 

Liebel F, Kaur S, Ruvolo E, Kollias N and Southall MD: Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes. J Invest Dermatol. 132:1901–1907. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Rinnerthaler M, Bischof J, Streubel MK, Trost A and Richter K: Oxidative stress in aging human skin. Biomolecules. 5:545–589. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Pillai S, Oresajo C and Hayward J: Ultraviolet radiation and skin aging: Roles of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation-induced matrix degradation-a review. Int J Cosmet Sci. 27:17–34. 2005. View Article : Google Scholar

13 

Bickers DR and Athar M: Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol. 126:2565–2575. 2006. View Article : Google Scholar : PubMed/NCBI

14 

Davis RJ: The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 268:14553–14556. 1993.PubMed/NCBI

15 

Sun S, Jiang P, Su W, Xiang Y, Li J, Zeng L and Yang S: Wild chrysanthemum extract prevents UVB radiation-induced acute cell death and photoaging. Cytotechnology. 68:229–240. 2016. View Article : Google Scholar :

16 

Adams CA: The probiotic paradox: Live and dead cells are biological response modifiers. Nutr Res Rev. 23:37–46. 2010. View Article : Google Scholar : PubMed/NCBI

17 

Liu Z, Liu W, Ran C, Hu J and Zhou Z: Abrupt suspension of probiotics administration may increase host pathgen susceptibility by inducing gut dysbiosis. Sci Rep. 6:232142016. View Article : Google Scholar

18 

Gerritsen J, Smidt H, Rijkers GT and de Vos WM: Intestinal microbiota in human health and disease: The impact of probiotics. Genes Nutr. 6:209–240. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Satoh T, Murata M, Iwabuchi N, Odamaki T, Wakabayashi H, Yamauchi K, Abe F and Xiao JZ: Effect of Bifidobacterium breve B-3 on skin photoaging induced by chronic UV irradiation in mice. Benef Microbes. 6:497–504. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Bouilly-Gauthier D, Jeannes C, Maubert Y, Duteil L, Queille-Roussel C, Piccardi N, Montastier C, Manissier P, Piérard G and Ortonne JP: Clinical evidence of benefits of a dietary supplement containing probiotic and carotenoids on ultraviolet-induced skin damage. Br J Dermatol. 163:536–543. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

22 

Smith WP: Epidermal and dermal effects of topical lactic acid. J Am Acad Dermatol. 35:388–391. 1996. View Article : Google Scholar : PubMed/NCBI

23 

LeBlanc JG, Chain F, Martín R, Bermúdez-Humarán LG, Courau S and Lagella P: Beneficial effects on host energy metabolism of short-chin fatty acids and vitamins produced by commensal and probiotic bacteria. Microb Cell Fact. 16:792017. View Article : Google Scholar

24 

Preidis GA, Hill C, Guerrant RL, Ramakrishna BS, Tannock GW and Versalovic J: Probiotics, enteric and diarrheal disease, and global health. Gastroenterology. 140:8–14. 2011. View Article : Google Scholar

25 

Khavkin J and Ellis DA: Aging skin: Histology, physiology, and pathology. Facial Plast Surg Clin North Am. 19:229–234. 2011. View Article : Google Scholar : PubMed/NCBI

26 

El-Domyati M, Attia S, Saleh F, Brown D, Birk DE, Gasparro F, Ahmad H and Uitto J: Intrinsic aging vs photoaging: A comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol. 11:398–405. 2002. View Article : Google Scholar : PubMed/NCBI

27 

Tobin DJ: Introduction to skin aging. J Tissue Viability. 26:37–46. 2017. View Article : Google Scholar

28 

Scharffetter-Kochanek K, Brenneisen P, Wenk J, Herrmann G, Ma W, Kuhr L, Meewes C and Wlaschek M: Photoaging of the skin from phenotype to mechanisms. Exp Gerontol. 35:307–316. 2000. View Article : Google Scholar : PubMed/NCBI

29 

Chung JH, Seo JY, Lee MK, Eun HC, Lee JH, Kang S, Fisher GJ and Voorhees JJ: Ultraviolet modulation of human macrophage metalloelastase in human skin in vivo. J Invest Dermatol. 119:507–512. 2002. View Article : Google Scholar : PubMed/NCBI

30 

Sherratt MJ: Tissue elasticity and the ageing elastic fibre. Age (Dordr). 31:305–325. 2009. View Article : Google Scholar

31 

Bosset S, Bonnet-Duquennoy M, Barré P, Chalon A, Lazou K, Kurfurst R, Bonté F, Schnébert S, Disant F, Le Varlet B, et al: Decreased expression of keratinocyte beta1 integrins in chronically sun-exposed skin in vivo. Br J Dermatol. 148:770–778. 2003. View Article : Google Scholar : PubMed/NCBI

32 

Bernerd F and Asselineau D: Successive alteration and recovery of epidermal differentiation and morphogenesis after specific UVB-damages in skin reconstructed in vitro. Dev Biol. 183:123–138. 1997. View Article : Google Scholar : PubMed/NCBI

33 

Chung JH, Seo JY, Choi HR, Lee MK, Youn CS, Rhie G, Cho KH, Kim KH, Park KC and Eun HC: Modulation of skin collagen metabolism in aged and photoaged human skin in vivo. J Invest Dermatol. 117:1218–1224. 2001. View Article : Google Scholar : PubMed/NCBI

34 

Calleja-Agius J, Brincat M and Borg M: Skin connective tissue and ageing. Best Pract Res Clin Obstet Gynaecol. 27:727–740. 2013. View Article : Google Scholar : PubMed/NCBI

35 

Quan T, Qin Z, Xia W, Shao Y, Voorhees JJ and Fisher GJ: Matrix-degrading metalloproteinases in photoaging. J Investig Dermatol Symp Proc. 14:20–24. 2009. View Article : Google Scholar : PubMed/NCBI

36 

Yaar M and Gilchrest BA: Photoageing: Mechanism, prevention and therapy. Br J Dermatol. 157:874–887. 2007. View Article : Google Scholar : PubMed/NCBI

37 

Philips N, Auler S, Hugo R and Gonzalez S: Beneficial regulation of matrix metalloproteinases for skin health. Enzyme Res. 2011:4272852011. View Article : Google Scholar : PubMed/NCBI

38 

Kähäri VM and Saarialho-Kere U: Matrix metalloproteinases in skin. Exp Dermatol. 6:199–213. 1997. View Article : Google Scholar

39 

Poljšak B and Dahmane R: Free radicals and extrinsic skin aging. Dermatol Res Pract. 2012:1352062012. View Article : Google Scholar

40 

Clydesdale GJ, Dandie GW and Muller HK: Ultraviolet light induced injury: Immunological and inflammatory effects. Immunol Cell Biol. 79:547–568. 2001. View Article : Google Scholar

41 

Kirnbauer R, Köck A, Neuner P, Förster E, Krutmann J, Urbanski A, Schauer E, Ansel JC, Schwarz T and Luger TA: Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. J Invest Dermatol. 96:484–489. 1991. View Article : Google Scholar : PubMed/NCBI

42 

Roux PP and Blenis J: ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev. 68:320–344. 2004. View Article : Google Scholar : PubMed/NCBI

43 

López-Camarillo C, Ocampo EA, Casamichana ML, Pérez-Plasencia C, Alvarez-Sánchez E and Marchat LA: Protein kinases and transcription factors activation in response to UV-radiation of skin: Implications for carcinogenesis. Int J Mol Sci. 13:142–172. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Im AR, Lee B, Kang DJ and Chae S: Protective effects of tyndallized Lactobacillus acidophilus IDCC 3302 against UVB‑induced photodamage to epidermal keratinocytes cells. Int J Mol Med 43: 2499-2506, 2019.
APA
Im, A., Lee, B., Kang, D., & Chae, S. (2019). Protective effects of tyndallized Lactobacillus acidophilus IDCC 3302 against UVB‑induced photodamage to epidermal keratinocytes cells. International Journal of Molecular Medicine, 43, 2499-2506. https://doi.org/10.3892/ijmm.2019.4161
MLA
Im, A., Lee, B., Kang, D., Chae, S."Protective effects of tyndallized Lactobacillus acidophilus IDCC 3302 against UVB‑induced photodamage to epidermal keratinocytes cells". International Journal of Molecular Medicine 43.6 (2019): 2499-2506.
Chicago
Im, A., Lee, B., Kang, D., Chae, S."Protective effects of tyndallized Lactobacillus acidophilus IDCC 3302 against UVB‑induced photodamage to epidermal keratinocytes cells". International Journal of Molecular Medicine 43, no. 6 (2019): 2499-2506. https://doi.org/10.3892/ijmm.2019.4161
Copy and paste a formatted citation
x
Spandidos Publications style
Im AR, Lee B, Kang DJ and Chae S: Protective effects of tyndallized Lactobacillus acidophilus IDCC 3302 against UVB‑induced photodamage to epidermal keratinocytes cells. Int J Mol Med 43: 2499-2506, 2019.
APA
Im, A., Lee, B., Kang, D., & Chae, S. (2019). Protective effects of tyndallized Lactobacillus acidophilus IDCC 3302 against UVB‑induced photodamage to epidermal keratinocytes cells. International Journal of Molecular Medicine, 43, 2499-2506. https://doi.org/10.3892/ijmm.2019.4161
MLA
Im, A., Lee, B., Kang, D., Chae, S."Protective effects of tyndallized Lactobacillus acidophilus IDCC 3302 against UVB‑induced photodamage to epidermal keratinocytes cells". International Journal of Molecular Medicine 43.6 (2019): 2499-2506.
Chicago
Im, A., Lee, B., Kang, D., Chae, S."Protective effects of tyndallized Lactobacillus acidophilus IDCC 3302 against UVB‑induced photodamage to epidermal keratinocytes cells". International Journal of Molecular Medicine 43, no. 6 (2019): 2499-2506. https://doi.org/10.3892/ijmm.2019.4161
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team